Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes
- 1 June 2008
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 57 (6) , 1674-1682
- https://doi.org/10.2337/db08-0083
Abstract
OBJECTIVE—Patients with diabetes often have dyslipidemia and increased postprandial lipidmia. Induction of diabetes in LDL receptor (Ldlr−/−) knockout mice also leads to marked dyslipidemia. The reasons for this are unclear. RESEARCH DESIGN AND METHODS—We placed Ldlr−/− and heterozygous LDL receptor knockout (Ldlr+/−) mice on a high-cholesterol (0.15%) diet, induced diabetes with streptozotocin (STZ), and assessed reasons for differences in plasma cholesterol. RESULTS—STZ-induced diabetic Ldlr−/− mice had plasma cholesterol levels more than double those of nondiabetic controls. Fast-performance liquid chromatography and ultracentrifugation showed an increase in both VLDL and LDL. Plasma VLDL became more cholesterol enriched, and both VLDL and LDL had a greater content of apolipoprotein (apo)E. In LDL the ratio of apoB48 to apoB100 was increased. ApoB production, assessed using [35S]methionine labeling in Triton WR1339–treated mice, was not increased in fasting STZ-induced diabetic mice. Similarly, postprandial lipoprotein production was not increased. Reduction of cholesterol in the diet to normalize the amount of cholesterol intake by the control and STZ-induced diabetic animals reduced plasma cholesterol levels in STZ-induced diabetic mice, but plasma cholesterol was still markedly elevated compared with nondiabetic controls. LDL from STZ-induced diabetic mice was cleared from the plasma and trapped more rapidly by livers of control mice. STZ treatment reduced liver expression of the proteoglycan sulfation enzyme, heparan sulfate N-deacetylase/N-sulfotrasferase-1, an effect that was reproduced in cultured hepatocytyes by a high glucose–containing medium. CONCLUSIONS—STZ-induced diabetic, cholesterol-fed mice developed hyperlipidemia due to a non-LDL receptor defect in clearance of circulating apoB-containing lipoproteins.Keywords
This publication has 46 references indexed in Scilit:
- Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family membersJournal of Clinical Investigation, 2007
- Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosisJournal of Lipid Research, 2006
- Diabetic Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceJournal of Clinical Investigation, 2005
- Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptorAtherosclerosis, 2005
- Scavenger Receptor BI Plays a Role in Facilitating Chylomicron MetabolismJournal of Biological Chemistry, 2004
- Retinol-Binding Protein-Deficient Mice: Biochemical Basis for Impaired VisionBiochemistry, 2002
- Severe Hypercholesterolemia, Hypertriglyceridemia, and Atherosclerosis in Mice Lacking Both Leptin and the Low Density Lipoprotein ReceptorPublished by Elsevier ,2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Increased High Density Lipoprotein (HDL), Defective Hepatic Catabolism of ApoA-I and ApoA-II, and Decreased ApoA-I mRNA inob/ob MiceJournal of Biological Chemistry, 1999